114 related articles for article (PubMed ID: 38232132)
1. Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial-Mesenchymal Transition and Arousing Immune Response.
Zhang M; Chen Y; Liu Z; Liu M; Wang Q
J Med Chem; 2024 Feb; 67(3):2031-2048. PubMed ID: 38232132
[TBL] [Abstract][Full Text] [Related]
2. Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents.
Zhang M; Li L; Li S; Liu Z; Zhang N; Sun B; Wang Z; Jia D; Liu M; Wang Q
J Med Chem; 2023 Mar; 66(5):3393-3410. PubMed ID: 36891739
[TBL] [Abstract][Full Text] [Related]
3. Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Li L; Zhang M; Jia D; Liu Z; Zhang N; Sun B; Wang Z; Liu M; Wang Q
Dalton Trans; 2022 Dec; 52(1):147-158. PubMed ID: 36472127
[TBL] [Abstract][Full Text] [Related]
4. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.
Zhang W; Peng C; Yan J; Chen P; Jiang C; Sang S; Yuan Y; Hong Y; Yao M
Phytomedicine; 2022 Jan; 94():153844. PubMed ID: 34785413
[TBL] [Abstract][Full Text] [Related]
5. Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer.
Ma J; Qi J; Li S; Zhang C; Wang H; Shao L; Yuan X; Sha Q
Technol Cancer Res Treat; 2020; 19():1533033820926591. PubMed ID: 32406319
[TBL] [Abstract][Full Text] [Related]
6. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
7. A series of ligustrazine platinum(IV) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects.
Chen Y; Li L; Liu Z; Liu M; Wang Q
Dalton Trans; 2023 Sep; 52(37):13097-13109. PubMed ID: 37664893
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
Feng P; Zhu L; Jie J; Yang P; Sheng N; Chen X; Chen X
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3587-3598. PubMed ID: 35960375
[TBL] [Abstract][Full Text] [Related]
10. Development of a series of flurbiprofen and zaltoprofen platinum(IV) complexes with anti-metastasis competence targeting COX-2, PD-L1 and DNA.
Li Z; Li L; Zhao W; Sun B; Liu Z; Liu M; Han J; Wang Z; Li D; Wang Q
Dalton Trans; 2022 Aug; 51(33):12604-12619. PubMed ID: 35924963
[TBL] [Abstract][Full Text] [Related]
11. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
12. Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response.
Li Z; Wang Q; Li L; Chen Y; Cui J; Liu M; Zhang N; Liu Z; Han J; Wang Z
J Med Chem; 2021 Dec; 64(24):17920-17935. PubMed ID: 34852203
[TBL] [Abstract][Full Text] [Related]
13. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway.
Peng L; Liu Z; Xiao J; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2017 Jul; 38(1):301-308. PubMed ID: 28586066
[TBL] [Abstract][Full Text] [Related]
15. Numerical modelling of WNT/β-catenin signal pathway in characterization of EMT of colorectal carcinoma cell lines after treatment with Pt(IV) complexes.
Šeklić DS; Đukić T; Milenković D; Jovanović MM; Živanović MN; Marković Z; Filipović N
Comput Methods Programs Biomed; 2022 Nov; 226():107158. PubMed ID: 36198204
[TBL] [Abstract][Full Text] [Related]
16. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
17. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
19. Abnormal activation of the Wnt3a/β-catenin signaling pathway promotes the expression of T-box transcription factor 3(TBX3) and the epithelial-mesenchymal transition pathway to mediate the occurrence of adenomyosis.
Li M; Li T; Jin T; Chen Y; Cheng L; Liang Q; Yan S; Li T; Ran Q; Chen W
Mol Biol Rep; 2023 Dec; 50(12):9935-9950. PubMed ID: 37878207
[TBL] [Abstract][Full Text] [Related]
20. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
